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Nora Janjan, M.D., FACP
Radiation therapy, because it effectively treats microscopic residual disease, has allowed multi-modality approaches
that expand the criteria for organ preservation. My research efforts in soft tissue sarcoma have focused on
improving rates of local control and limiting normal tissue toxicities by optimizing radiotherapeutic approaches
with brachytherapy and intraoperative irradiation. Brachytherapy has been used for de® nitive therapy of sarcomas
that are newly diagnosed or that have recurred within a previously irradiated area. Despite concerns about
wound healing and radiation effects on small vessels, we have shown that the viability of myocutaneous ¯ ap
reconstruction is not compromised by brachytherapy. Providing comparable rates of local control, brachy-
therapy also proved to be an efficient, cost-effective alternative to conventional external beam radiation. Func-
tion preservation is an integral issue in quality of life, especially among patients with recurrent sarcoma in which
limb-sparing surgical interventions are often facilitated by brachytherapy. Intraoperative irradiation and other
techniques to exclude the small bowel from the external beam radiation portal have been applied to reduce risk
of local recurrence in retroperitoneal sarcomas. Supportive care, that involves control of disease and treatment-
related symptoms, has also been a research priority.
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Marc Horowitz, M.D., is a Professer of Pediatrics at Baylor College of Medicine. He graduated from the
University of Southern California School of Medicine and completed his postgraduate training at the Children’s
Hospital of Los Angeles, University of California at San Diego and the National Cancer Institute. He has
published extensively in the area of development of new therapy for children with solid tumors including those
of the central nervous system and bone and soft tissue sarcomas. He is Director of the Texas Children’s Cancer
Center’s Solid Tumor Program and is responsible for all of the clinical and research activities relating to children
with solid tumors. His clinical research activities include the development of protocols for children with solid
tumors including studies of osteosarcoma, Ewing’s sarcoma, neuroblastoma and high- and low-grade glioma, as
well as gene therapy for recurrent brain tumors. Dr. Horowitz is also interested in medical informatics and is a
developer of an electronic patient record that is in use at the Texas Children’s Cancer Center.
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Professor Barrett is one of the Multi-disciplinary Bone and SoftTissue Sarcoma Group at the Beatson Oncology
Centre, Western In® rmary, Glasgow. She is the co-author of two books, Practical Radiotherapy Planning and
Cancer in Children and is currently the President of the European Society of Therapeutic Radiation Oncology.
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Bert van Geel was born in 1947 and became a surgeon in 1984. In that year he started his work as a surgical
oncologist in the Daniel den Hoed Cancer Center (formally Rotterdam Radiotherapeutic Institute).The main
goal was to found a surgical department essential for a good running cancer center. Nowadays he is mainly
interested in thoracic and sarcoma surgery. One of the achievements is that he was the founder of the national
sarcoma group (nederlandse werkgroep weke delen tumoren) and that this group was able to de® ne a national
concensus in the diagnosis and treatment of sarcoma. He is an active member of the local treatment group of
the EORTC soft tissue and bone sarcoma group and the CTOS.
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